Announcements Trials
Browse Landscape

Status

Recruiting 2Completed 2Withdrawn 1Terminated 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Carcinoma, Non-Small-Cell Lung 3Breast Neoplasms 2Thyroid Neoplasms 1Oropharyngeal Neoplasms 1Neoplasms 1Multiple Myeloma 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Lymphoma 1Lung Neoplasms 1Liver Cirrhosis 1HER2-positive Breast Cancer 1Glioma 1Glioblastoma 1Cytoreductive Surgery 1Carcinoma, Hepatocellular 1Carcinoma 1Breast Neoplasms, Male 1

Interventions

vandetanib 1pembrolizumab 1lenvatinib 1fosbretabulin 1fludarabine 1combretastatin 1aldesleukin 1Water 1Thyroxine 1Thyrotropin-Releasing Hormone 1Tea 1Paclitaxel 1Milk 1Iodine-124 1Iodine-123 1Fluorodeoxyglucose F18 1Drug Therapy 1Docetaxel 1DNA 1Cyclophosphamide 1Coffee 1Carboplatin 1Biopsy, Fine-Needle 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Thyroid Neoplasms × Fluorodeoxyglucose F18 × Clear all
NCT00373711 2022-06-21

Comparison of I-124 PET/CT, F-18 FDG PET/CT & I-123 Whole Body Scintigraphy for Recurrent Thyroid CA

Stanford University

Withdrawn
Head & Neck

Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡